Visual Evoked Potentials as a Readout of Cortical Function in Infants with Tuberous Sclerosis Complex

Journal of Child Neurology

Volumn 31, Issue 2, 2016, Pages 195-202

  Varcin, Kandice J ^a   Nelson, Charles A ^a,b   Ko, Jordan ^c   Sahin, Mustafa ^d   Wu, Joyce Y ^e   Jeste, Shafali Spurling ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

event related potentials; neurodevelopmental disorders; tuberous sclerosis complex; visual evoked potentials; visual processing

Indexed keywords

ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EPILEPSY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; INFANT; INTELLECTUAL IMPAIRMENT; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STRIATE CORTEX; TUBEROUS SCLEROSIS; VISUAL INFORMATION; VISUAL STIMULATION; BRAIN CORTEX; CLINICAL TRIAL; COMPLICATION; ELECTROENCEPHALOGRAPHY; LONGITUDINAL STUDY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHOTOSTIMULATION; PHYSIOLOGY; VISION; VISUAL EVOKED POTENTIAL;

CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; PHOTIC STIMULATION; TUBEROUS SCLEROSIS; VISUAL PERCEPTION;

EID: 84954154201     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073815587328     Document Type: Article

References (40)

1. Sparagana SP, Roach ES,. Tuberous sclerosis complex. Curr Opin Neurol. 2000; 13: 115-119.
2. de Vries PJ,. Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex. Neurotherapeutics. 2010; 7: 275-282.
3. Orlova KA, Crino PB,. The tuberous sclerosis complex. Ann NY Acad Sci. 2010; 1184: 87-105.
4. Crino PB, Nathanson KL, Henske EP,. The tuberous sclerosis complex. N Engl J Med. 2006; 355; 1345-1356.
5. Curatolo P, Bombardieri R, Jozwiak S,. Tuberous sclerosis. Lancet. 2008; 372: 657-668.
6. Joinson C, O'Callaghan FJ, Osborne JP, et al. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med. 2003; 33: 335-344.
7. Humphrey A, Williams J, Pinto E, et al. A prospective longitudinal study of early cognitive development in tuberous sclerosis-a clinic based study. Eur Child Adolesc Psychiatry. 2004; 13: 159-165.
8. Zaroff CM, Devinsky O, Miles D, et al. Cognitive and behavioral correlates of tuberous sclerosis complex. J Child Neurol. 2004; 19: 847-852.
9. de Vries PJ, Hunt A, Bolton PF,. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur Child Adolesc Psychiatry. 2007; 16: 16-24.
10. Winterkorn EB, Pulsifier MB, Thiele EA,. Cognitive prognosis of patients with tuberous sclerosis complex. Neurology. 2007; 68: 62-64.
11. Jansen FE, Vincken Kl, Algra A, et al. Cognitive impairments in tuberous sclerosis complex is a multifactorial condition. Neurology. 2008; 70: 916-923.
12. Jeste SS, Sahin M, Bolton P, et al. Characterization of autism in young children with tuberous sclerosis complex. J Child Neurol. 2008; 23: 520-525.
13. Curatolo P, Napolioni V, Moavero R,. Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. J Child Neurol. 2010; 25: 873-880. Erratum in: J Child Neurol. 2012;27:275.
14. Knox S, Ge H, Dimitroff BD, et al. Mechanisms of TSC-mediated control of synapse assembly and axon guidance. PLoS One. 2007; 2: e375.
15. Nie D, Di Nardo A, Han JM, et al. Tsc2-Rheb signaling regulates EphA-mediated axon guidance. Nat Neurosci. 2010; 13: 163-172.
16. Krishnan ML, Commowick O, Jeste SS, et al. Diffusion features of white matter in tuberous sclerosis with tractography. Pediatr Neurol. 2010; 42: 101-106.
17. Jeste SS, Hirsch S, Vogel-Farley V, et al. Atypical face processing in children with tuberous sclerosis complex. J Child Neurol. 2013; 28: 1569-1576.
18. Jeste SS, Wu JY, Senturk D, et al. Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex. Neurology. 2014; 83: 160-168.
19. Odom JV, Bach M, Brigell M, et al. ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol. 2010; 120: 111-119.
20. Zemon V, Kaplan E, Ratliff F,. Bicuculline enhances a negative component and diminishes a positive component of the visual evoked cortical potential in the cat. P Natl Acad Sci U S A. 1980; 77: 7476-7478.
21. Schroeder CE, Tenke CE, Givre SJ, et al. Striate cortical contribution to the surface-recorded pattern-reversal VEP in the alert monkey. Vision Res. 1991; 31: 1143-1157.
22. Kelly JP, Darvas F, Weiss AH,. Waveform variance and latency jitter of the visual evoked potential in childhood. Doc Ophthalmol. 2014; 128: 1-12.
23. Kau T, Zrenner E, Boergen KP, Hainzlmaier E,. Recording of visual evoked potentials in infants: characteristics and optimization of the method. Fortschr Ophthalmol. 1989; 86: 497-501.
24. Walsh P, Kane N, Butler S,. The clinical role of evoked potentials. J Neurol Neurosurg Psychiatry. 2005; 76: ii16-ii22.
25. Moskowitz A, Sokol S,. Developmental changes in the human visual system as reflected by the pattern reversal VEP. Electroencephalogr Clin Neurophysiol. 1983; 56: 1-15.
26. Roy MS, Barsoum-Homsy M, Orquin J, et al. Maturation of binocular pattern visual evoked potentials in normal full-term and preterm infants from 1 to 6 months of age. Pediatr Res. 1995; 37: 140-144.
27. Malcolm CA, McCulloch DL, Sheperd AJ,. Pattern-reversal visual evoked potentials in infants: gender differences during early visual maturation. Dev Med Child Neurol. 2002; 44: 345-351.
28. Sokol S, Jones K,. Implicit time of pattern visual evoked potentials in infants: an index of maturation. Vision Res. 1979; 19: 747-755.
29. McCulloch DL, Skarf B,. Development of the human visual system: monocular and binocular pattern VEP latency. Invest Ophth Vis Sci. 1991; 32: 2372-2381.
30. Mullen EM,. Mullen Scales of Early Learning. Circle Pines, MN: American Guidance Services, Inc; 1995.
31. Rowley SA, O'Callaghan FJ, Osborne JP,. Ophthalmic manifestations of tuberous sclerosis: a population based study. Br J Ophthalmol. 2001; 85: 420-423.
32. Robertson DM,. Ophthalmic findings. In: Gomez MR, ed. Tuberous Sclerosis Complex. 3rd ed. New York: Oxford University Press; 1999: 145-159.
33. Riikonen R, Rener-Primec Z, Carmant L, et al. Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicenter study. Dev Med Child Neurol. 2015; 57: 60-67.
34. Maguire M, Hemming K, Wild J, et al. Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia. 2010; 51: 2423-2431.
35. Harding GFA, Spencer JM, Wild JM, et al. Field-specific visual-evoked potentials: identifying field defects in vigabatrin-treated children. Neurology. 2002; 58: 1261-1265.
36. Harding GFA, Wild JM, Roberstson KA, et al. Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss. Neurology. 2000; 55: 347-352.
37. Mauguière F, Chauvel P, Dewailly J, et al. No effect of long-term vigabatrin treatment on CNS conduction in epileptic patients: results of a multicenter study of somatosensory and visual evoked potentials [Abstract]. Epilepsia. 1995; 36: S29.
38. Dawson G, Webb SJ, McPartland J,. Understanding the nature of face processing impairments in autism: insights from behavioral and electrophysiological studies. Dev Neuropsychol. 2005; 27: 403-424.
39. Haxby JV, Hoffman EA, Gobbini MI,. Human neural systems for face recognition and social communication. Biol Psychiatry. 2002; 51: 59-67.
40. Pei F, Baldassi S, Norcia AM,. Electrophysiological measures of low-level vision reveal spatial processing deficits and hemispheric asymmetry in autism spectrum disorder. J Vision. 2014; 14: 1-12.